Trevena Announces Wake Forest Baptist Health Joining OLINVYK® Clinical Outcomes Study

NEXT STORY
iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics
PREV STORY
Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

author_avatar
NASDAQ Market News

US FDA clears behold.ai’s AI algorithm for radiology triage

author_avatar
NASDAQ Market News

Leap Therapeutics Presents Biomarker Data from Clinical Study of DKN-01 in Combination with Paclitaxel in Esophageal Cancer

Durable responses observed in patients with Wnt-pathway genetic mutationsCAMBRIDGE, Mass., Jan. 19, 2017 (GLOBE ...

author_avatar
NASDAQ Market News